Top pharmaceutical R&D projects based on net present value May 2019

Vertex’s triple combination project was the most valuable research and development project in the pharmaceutical industry worldwide, based on its net present value (NPV) of almost 20 billion U.S. dollars, as of May 2019.

Global R&D spending

In 2018, global pharmaceutical industry expenditures for research and development amounted to just under 180 billion U.S. dollars. Total global R&D expenditures have been increasing with each consecutive year since 2012, reaching over 200 billion U.S. dollars by 2022. Some of 2018’s leading pharmaceutical companies, in terms of R&D spending, included Roche, Johnson & Johnson, and Novartis. Each of these companies invested over eight billion U.S. dollars that year. In terms of prescription sales, however, Pfizer led the list with over 45 billion U.S. dollars’ worth of Rx sales.

Pfizer

Pfizer is one of the world’s largest pharmaceutical corporations. Based in New York City, the American company generates a considerable amount of its revenue in the United States. In 2018, Pfizer earned just over 25 billion U.S. dollars’ worth of revenue in its American submarket, and close to 17 billion in other emerging markets.

Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2019

Region

Worldwide

Survey time period

as of May 2019

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.